A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Atlanta, GA · Macon, GA · +92 more sites
20 recruiting crohn's disease studies with a site in Atlanta, GA.
Sponsor: Hoffmann-La Roche
Atlanta, GA · Macon, GA · +92 more sites
Sponsor: Takeda
Atlanta, GA · Decatur, GA · +98 more sites
Sponsor: Merck Sharp & Dohme LLC
Atlanta, GA · Decatur, GA · Macon, GA · +84 more sites
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Atlanta, GA · +23 more sites
Sponsor: Eli Lilly and Company
Atlanta, GA · +13 more sites
Sponsor: Eli Lilly and Company
Atlanta, GA · +13 more sites
Sponsor: Eli Lilly and Company
Atlanta, GA · +9 more sites
Sponsor: Eli Lilly and Company
Atlanta, GA · +13 more sites
Sponsor: National Cancer Institute (NCI)
Atlanta, GA · +50 more sites
Sponsor: Hoffmann-La Roche
Atlanta, GA · +60 more sites
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · +12 more sites
Sponsor: Takeda
Atlanta, GA · Decatur, GA · +28 more sites
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · +4 more sites
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · Macon, GA · +58 more sites
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · Macon, GA · +36 more sites
Sponsor: Sanofi
Atlanta, GA · Sandy Springs, GA · Snellville, GA · +122 more sites
Sponsor: Connecticut Children's Medical Center
Atlanta, GA · +21 more sites
Sponsor: Takeda
Atlanta, GA · +21 more sites
Sponsor: Takeda
Atlanta, GA · +21 more sites
Sponsor: Mirador Therapeutics, Inc.
Atlanta, GA · Snellville, GA · +44 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.